Literature DB >> 17301131

Production of infectious hepatitis C virus of various genotypes in cell cultures.

Takanobu Kato1, Takuya Matsumura, Theo Heller, Satoru Saito, Ronda K Sapp, Krishna Murthy, Takaji Wakita, T Jake Liang.   

Abstract

A unique hepatitis C virus (HCV) strain JFH-1 has been shown to replicate efficiently in cell culture with production of infectious HCV. We previously developed a DNA expression system containing HCV cDNA flanked by two self-cleaving ribozymes to generate HCV particles in cell culture. In this study, we produced HCV particles of various genotypes, including 1a (H77), 1b (CG1b), and 2a (J6 and JFH-1), in the HCV-ribozyme system. The constructs also contain the secreted alkaline phosphatase gene to control for transfection efficiency and the effects of culture conditions. After transfection into the Huh7-derived cell line Huh7.5.1, continuous HCV replication and secretion were confirmed by the detection of HCV RNA and core antigen in the culture medium. HCV replication levels of strains H77, CG1b, and J6 were comparable, whereas the JFH-1 strain replicates at a substantially higher level than the other strains. To evaluate the infectivity in vitro, the culture medium of JFH-1-transfected cells was inoculated into naive Huh7.5.1 cells. HCV proteins were detected by immunofluorescence 3 days after inoculation. To evaluate the infectivity in vivo, the culture medium from HCV genotype 1b-transfected cells was inoculated into a chimpanzee and caused a typical course of HCV infection. The HCV 1b propagated in vitro and in vivo had sequences identical to those of the HCV genomic cDNA used for cell culture transfection. The development of culture systems for production of various HCV genotypes provides a valuable tool not only to study the replication and pathogenesis of HCV but also to screen for antivirals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301131      PMCID: PMC1900162          DOI: 10.1128/JVI.02334-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Authors:  T J Liang; B Rehermann; L B Seeff; J H Hoofnagle
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

2.  Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.

Authors:  T Kato; A Furusaka; M Miyamoto; T Date; K Yasui; J Hiramoto; K Nagayama; T Tanaka; T Wakita
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

3.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

4.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Akihiro Furusaka; Katsutoshi Tokushige; Masashi Mizokami; Takaji Wakita
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

Review 5.  Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Authors:  Leonard B Seeff; Jay H Hoofnagle
Journal:  Clin Liver Dis       Date:  2003-02       Impact factor: 6.126

6.  Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Authors:  Marian E Major; Kathleen Mihalik; Montserrat Puig; Barbara Rehermann; Michelina Nascimbeni; Charles M Rice; Stephen M Feinstone
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Processing of hepatitis C virus core protein is regulated by its C-terminal sequence.

Authors:  Takanobu Kato; Michiko Miyamoto; Akihiro Furusaka; Tomoko Date; Kotaro Yasui; Junko Kato; Shozo Matsushima; Tatsuji Komatsu; Takaji Wakita
Journal:  J Med Virol       Date:  2003-03       Impact factor: 2.327

8.  Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus.

Authors:  M Thomson; M Nascimbeni; S Gonzales; K K Murthy; B Rehermann; T J Liang
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  41 in total

1.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 2.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

3.  Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.

Authors:  Jin-Ching Lee; Chin-Kai Tseng; Kung-Chia Young; Hung-Yu Sun; Shainn-Wei Wang; Wei-Chun Chen; Chun-Kuang Lin; Yu-Hsuan Wu
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.

Authors:  Véronique Pène; Qisheng Li; Catherine Sodroski; Ching-Sheng Hsu; T Jake Liang
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

6.  N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.

Authors:  Cameron J Schweitzer; Fang Zhang; Audrey Boyer; Kristin Valdez; Maggie Cam; T Jake Liang
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

7.  Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.

Authors:  Gamal A Elmowalid; Ming Qiao; Sook-Hyang Jeong; Brian B Borg; Thomas F Baumert; Ronda K Sapp; Zongyi Hu; Krishna Murthy; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

8.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation.

Authors:  Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; T Jake Liang; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

9.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

10.  Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.

Authors:  Heidi Barth; Eva K Schnober; Christoph Neumann-Haefelin; Christine Thumann; Mirjam B Zeisel; Helmut M Diepolder; Zongyi Hu; T Jake Liang; Hubert E Blum; Robert Thimme; Mélanie Lambotin; Thomas F Baumert
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.